| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arteriosclerosis Obliterans | D001162 | 8 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Arthritis, Experimental | D001169 | 24 associated lipids |
| Arthritis, Juvenile | D001171 | 8 associated lipids |
| Arthus Reaction | D001183 | 8 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Asthenia | D001247 | 5 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Bartter Syndrome | D001477 | 5 associated lipids |
| Behcet Syndrome | D001528 | 7 associated lipids |
| Biliary Tract Neoplasms | D001661 | 7 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Blood Platelet Disorders | D001791 | 12 associated lipids |
| Bluetongue | D001819 | 1 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Bronchial Spasm | D001986 | 18 associated lipids |
| Bronchitis | D001991 | 6 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Pärsson HN et al. | Maintaining carotid flow by shunting during carotid endarterectomy diminishes the inflammatory response mediating ischaemic brain injury. | 2000 | Eur J Vasc Endovasc Surg | pmid:10727360 |
| Zaitsu M et al. | Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. | 2000 | J. Infect. Dis. | pmid:10720537 |
| Okada S et al. | Perfusion of the hypothalamic paraventricular nucleus with N-methyl-D-aspartate produces thromboxane A2 and centrally activates adrenomedullary outflow in rats. | 2000 | Neuroscience | pmid:10717438 |
| Weber AA et al. | 40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. | 2000 | Thromb. Res. | pmid:10709913 |
| Suntres ZE and Shek PN | Prophylaxis against lipopolysaccharide-induced lung injuries by liposome-entrapped dexamethasone in rats. | 2000 | Biochem. Pharmacol. | pmid:10704946 |
| Nosál R and Jancinová V | Nonreceptor interactions in the pharmacology of blood platelets. | 1999 | Gen. Physiol. Biophys. | pmid:10703730 |
| Tegeder I et al. | Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. | 2000 | J. Pharmacol. Exp. Ther. | pmid:10688636 |
| Nagano K et al. | Prostanoids regulate proliferation of vascular smooth muscle cells induced by arginine vasopressin. | 2000 | Eur. J. Pharmacol. | pmid:10686292 |
| Zeng W et al. | [Relationship between PGI2, TXA2 and threatened preterm]. | 1998 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:10684102 |
| De La Cruz JP et al. | Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus. | 2000 | Thromb. Res. | pmid:10680643 |
| Wu TM et al. | Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. | 2000 | Thromb. Res. | pmid:10674405 |
| Okumura M et al. | Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes. | 2000 | Life Sci. | pmid:10670825 |
| Leese PT et al. | Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. | 2000 | J Clin Pharmacol | pmid:10664917 |
| Matsumoto H and Nakao T | Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome. | 2000 | Clin. Nephrol. | pmid:10661487 |
| Hansen JM et al. | Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man. | 1999 | J. Hypertens. | pmid:10658936 |
| Landoni MF et al. | Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. | 1999 | J. Vet. Pharmacol. Ther. | pmid:10651463 |
| Chou TC et al. | Mechanism of inhibition of platelet aggregation by HCL-31D. | 2000 | Eur. J. Pharmacol. | pmid:10650152 |
| Montini G et al. | Renal glomerular response to the inhibition of prostaglandin E2 synthesis and protein loading after the relief of unilateral ureteropelvic junction obstruction. | 2000 | J. Urol. | pmid:10647684 |
| Gajdos M et al. | [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. | 1999 | Bratisl Lek Listy | pmid:10645034 |
| Stewart KG et al. | Estrogen decreases prostaglandin H synthase products from endothelial cells. | 1999 Nov-Dec | J. Soc. Gynecol. Investig. | pmid:10643586 |
| González E et al. | Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway. | 1999 | Nitric Oxide | pmid:10637124 |
| Miura M and Kurimoto F | [Thromboxane B2 (TXB2)]. | 1999 | Nippon Rinsho | pmid:10635957 |
| Perneby C et al. | Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. | 1999 | Thromb. Res. | pmid:10632465 |
| Dahlin KL et al. | Amitriptyline-induced release of endothelin-1 in isolated perfused and ventilated rat lungs. | 1999 | Pharmacol. Toxicol. | pmid:10628905 |
| Tanus-Santos JE et al. | The hemodynamic effects of endothelin receptor antagonism during a venous air infusion in dogs. | 2000 | Anesth. Analg. | pmid:10624986 |
| Uriu K et al. | Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat. | 1999 Jul-Aug | J. Diabetes Complicat. | pmid:10616856 |
| Ferro D et al. | Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. | 1999 | Arthritis Rheum. | pmid:10616019 |
| Eldor A et al. | A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. | 1999 | Br. J. Haematol. | pmid:10606878 |
| Reis F et al. | The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. | 1999 | Thromb. Res. | pmid:10605951 |
| De La Cruz JP et al. | Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. | 1999 | Br. J. Pharmacol. | pmid:10602334 |
| Chou TC and Li CY | Inhibitory mechanisms of dantrolene on platelet aggregation. | 1999 | Thromb. Res. | pmid:10593433 |
| Kohda N et al. | Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. | 1999 | Thromb. Res. | pmid:10593428 |
| Hoch B and Bernhard M | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593170 |
| Hishinuma T et al. | Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593168 |
| Mizugaki M et al. | Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593167 |
| Pavord ID et al. | Induced sputum eicosanoid concentrations in asthma. | 1999 | Am. J. Respir. Crit. Care Med. | pmid:10588604 |
| Pirich C et al. | Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. | 1999 | Thromb. Res. | pmid:10588465 |
| Gallery ED et al. | In vitro human decidual endothelial cell thromboxane secretion in preeclampsia is not abnormal. | 1999 | Hypertens Pregnancy | pmid:10586525 |
| Vijaya Kumar M et al. | The anhydrous milk fat, ghee, lowers serum prostaglandins and secretion of leukotrienes by rat peritoneal macrophages. | 1999 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:10574649 |
| Castellani S et al. | Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. | 1999 | Hypertension | pmid:10567190 |
| Titos E et al. | Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). | 1999 | Am. J. Physiol. | pmid:10564079 |
| Heller A et al. | Pancreatitis-associated protein protects the lung from leukocyte-induced injury. | 1999 | Anesthesiology | pmid:10551593 |
| Hirakata H et al. | Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. | 1999 | Anesthesiology | pmid:10551587 |
| Nemcova S et al. | Cyclic nucleotides and production of prostanoids in human varicose veins. | 1999 | J. Vasc. Surg. | pmid:10550185 |
| Reeves JH et al. | Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. | 1999 | Crit. Care Med. | pmid:10548188 |
| de Meijer A et al. | Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. | 1999 | Clin. Pharmacol. Ther. | pmid:10546927 |
| Pearl JM et al. | Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass. | 1999 | Ann. Thorac. Surg. | pmid:10543508 |
| Chou TC et al. | Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. | 1999 | Biochem. Pharmacol. | pmid:10535758 |
| Serebruany VL et al. | Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarction. | 1999 | Life Sci. | pmid:10530802 |
| Véricel E et al. | The influence of low intake of n-3 fatty acids on platelets in elderly people. | 1999 | Atherosclerosis | pmid:10525140 |